Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO RESEARCH IN OPHTHALMOLOGY

Retinal section from a mouse model featuring cell nuclei, inhibitory cells and intrinsically photosensitive retinal ganglion cells

January 2020

OPHTHALMOLOGY

SITE OF FLOW RESISTANCE IN GLAUCOMA IDENTIFIED

Featuring: Mark Johnson, PhD

Northwestern Medicine scientists may have solved a 150-year old mystery of glaucoma: what causes elevated pressure in the eye?

According to findings published in Proceedings of the National Academy of Sciences, the answer lies within in the wall of in a small vessel in the eye called the Schlemm’s canal endothelium, the last stop for ocular fluid as it travels out of the eye to the bloodstream. In glaucoma, this layer of cells becomes abnormally stiff, preventing fluid from flowing out of the eye and leading to increased intra-ocular pressure.

“We’ve localized exactly where the change is occurring in glaucoma,” said Mark Johnson, PhD, professor of Ophthalmology and of Biomedical Engineering at the McCormick School of Engineering. “This could be very significant in terms of finding a cure for this disease.”

The eye uses a transparent fluid called aqueous humor for nutrition; the fluid is secreted from behind the iris, circulates past the lens and cornea before exiting the eye through a complicated pathway in the sclera. There, the aqueous humor moves though a fine tissue called the trabecular meshwork and must cross Schlemm’s canal endothelium — the lining of the vessel — before reaching Schlemm’s canal proper, which dispenses aqueous humor into the bloodstream.

In glaucoma, however, this outflow is blocked, causing a buildup of aqueous humor and raising pressure throughout the eye. This has been known this for nearly 150 years, but up until now the precise location where this blockage occurs has been scientists.

“People have been looking at this outflow pathway for a long time and nobody’s been able to see exactly what’s different in glaucoma,” Johnson said.

Building on recent work that identified increased tissue stiffness in these areas, Johnson and his colleagues used atomic force microscopy to search for micro-level changes in tissue stiffness. They found that the trabecular meshwork hadn’t changed — instead, it was the lining of Schlemm’s canal that exhibited increased stiffness. In particular the substrate of the endothelial cells lining Schlemm’s canal was stiffer by an order of magnitude, according to the investigators.

To relate this increased stiffness to outflow resistance that would lead to elevated pressure in the eye, Johnson and his collaborators  observed small cellular bubbles called giant vacuoles, located in the Schlemm’s canal endothelium. Using these bubbles as “micro-pressure sensors,” they found that the increased ocular pressure in glaucomatous eyes was generated at this same location.  “In the exact region where you have increased stiffness, you are also seeing increased flow resistance,” Johnson said. “Right there, that’s what’s causing the increased pressure in glaucoma.”

Now that the location of increased stiffness and flow resistance in glaucoma has been identified, scientists can work to devise a cure for this chronic condition. A recently developed treatment for glaucoma uses rho-kinase inhibitors to soften the Schlemm’s canal cells and thereby lower outflow resistance and intraocular pressure. However, this treatment softens other cell types in the eye, causing side effects.

Instead, Johnson believes that specifically targeting the Schlemm’s canal endothelium cells could result in a longer-lasting and more specific treatment. “If we can figure out some way to genetically target the Schlemm’s canal cells, we can make them softer,” Johnson said. “They’ll let more fluid flow through and that might be a more permanent solution to the problem.”
​
This study was supported by National Institutes of Health grants EY019696 and EY022634.

This article was originally published in the Feinberg School of Medicine News Center on January 13, 2020. 
Headshot of Dr. Mark Johnson
Mark Johnson, PhD, professor of McCormick School of Engineering and professor in the Division of Ophthalmology at Northwestern Medicine. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM Ophthalmologist

You May Also Like

Headshots of Dr. Surendra Basti and Dr. Robert Feder

December 2020

OPHTHALMOLOGY
Collaborations and Controversies: Femtosecond Laser Cataract Surgery
Retinal section from a mouse model featuring cell nuclei, inhibitory cells and intrinsically photosensitive retinal ganglion cells

January 2020

OPHTHALMOLOGY
Site of Flow Resistance in Glaucoma Identified
Headshot of Dr. Amani Fawzi

June 2019

OPHTHALMOLOGY
Eyes May Reveal Risk of Alzheimer’s Disease with Amani Fawzi, MD

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties